2023 Contract Pharmacy Developments: Surging Restrictions, State Law Legal Battles

In 2023, Arkansas became the first state to move to enforce a 340B contract pharmacy law as manufacturer restrictions continued to increase.
In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana, Health Centers Seek Dismissal of Contract Pharmacy Law Challenge

AstraZeneca headquarters
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.
Attorneys representing the state of Louisiana and 340B providers urged a federal judge to dismiss AstraZeneca’s lawsuit against Louisiana’s contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Takeda Becomes 29th Drugmaker to Implement 340B Contract Pharmacy Restrictions

Takeda 340B
Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.
Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Issues Draft Guidance Implementing 340B Provider Reporting Requirements

The Minnesota Department of Health finalized guidance for the state's new annual 340B covered entity reporting requirements.
Stakeholder comments are due Tuesday on Minnesota’s recently published guidance to implement one of the nation’s first state laws requiring [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Michigan to Increase Medicaid Payment for 340B Hospitals, Adds Reporting Requirements

The Michigan Department of Health and Human Services released a new 340B hospital billing and reporting rule.
At the start of 2024, Michigan 340B hospitals can bill the state at higher payment rates for outpatient drugs; later [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House Passes Healthcare Bill with 340B Provider Reporting Requirements

A sweeping healthcare package with 340B reporting provisions from Rep. Cathy McMorris Rodgers (R-Wash.) was passed by the House of Representatives.
The U.S. House of Representatives last night passed a sweeping healthcare package that would require 340B providers to publicly report [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Missouri State Senator to Reintroduce 340B Contract Pharmacy, PBM Protection Bill

The Missouri state senate recently passed a 340B contract pharmacy access bill.
A Missouri state senator has filed to reintroduce a bill that would bar drugmaker 340B contract pharmacy restrictions and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Wisconsin Assembly Bill Introduced to Bar PBM Practices Against 340B Providers

Wisconsin lawmakers have introduced bills in both legislative chambers that would bar PBMs from differentially reimbursing providers on the basis of their 340B status.
Just a week after Wisconsin state senators introduced a bipartisan bill to bar disparate treatment of 340B providers by pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House Committee Approves PBM Transparency Bill with 340B Provision

The House E&C Committee on Dec. 6 unanimously approved a PBM transparency bill with a 340B program provision.
Lawmakers on a key House committee approved a pharmacy benefit manager (PBM) transparency bill on Wednesday that would require PBMs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Senior GOP Senators Suggest 340B Linked to Generic Drug Shortages

Sen. Mike Crapo (R-Idaho), ranking member of the Senate Finance Committee, said penny pricing under 340B warranted “serious scrutiny in the context of generic products.”
Two Republican Senators on an influential committee suggested during a hearing on Tuesday that 340B discounts could contribute to certain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live